XML 75 R4.htm IDEA: XBRL DOCUMENT v3.20.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Income Statement [Abstract]    
Net revenues $ 77,122 $ 88,105
Costs and expenses:    
Cost of revenues [1] 35,471 38,953
Research and development 19,788 19,681
Selling, general and administrative 26,344 29,246
Restructuring charges 1,450 421
Depreciation and amortization 11,356 20,143
Total costs and expenses [1] 94,409 108,444
Loss from continuing operations (17,287) (20,339)
Interest income 58 189
Interest expense (245) (585)
Gain (loss) on extinguishment of debt 0 387
Other Income, net 1,692 463
Equity method investment loss 0 (1,243)
Loss from continuing operations, before taxes (15,782) (21,128)
Benefit for income taxes 12,432 1,391
Net loss (3,350) (19,737)
Net loss attributable to redeemable noncontrolling interests (17) (313)
Preferred stock dividend (8,909) (7,537)
Net loss attributable to Synchronoss $ (12,276) $ (27,587)
Earnings per share    
Basic (in dollars per share) $ (0.30) $ (0.68)
Diluted (in dollars per share) $ (0.30) $ (0.68)
Weighted-average common shares outstanding:    
Basic (in shares) 41,483 40,320
Diluted (in shares) 41,483 40,320
[1] Cost of revenues excludes depreciation and amortization which are shown separately.